CNS PharmaceuticalsCNSP
13F holders, Q4 2025 (December 31)1holders −9
1new positions
0sold out
$7.06avg. 13F price*
At the end of Q4 2025, 1 institutions reported holding CNS Pharmaceuticals Inc. (CNSP) in their 13F filings, down 9 from Q2 2025. 1 opened new positions and 0 sold out. The largest holder was Sound Income Strategies, LLC ($113).
- Company
- CNS Pharmaceuticals Inc.
- CUSIP
- 18978H409
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $113 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q4 2025: 16 shares bought, net +16 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Sound Income Strategies, LLC | 0.00% | New | 16 | $113 |
"% of holder's portfolio" is CNSP's weight in each manager's 13F, not the share of CNS Pharmaceuticals Inc. the manager owns.